Marijuana in the Obstetric Population

Size: px
Start display at page:

Download "Marijuana in the Obstetric Population"

Transcription

1 Marijuana in the Obstetric Population Brittany MacGregor PGY 1 on behalf of Sophia Lenson PGY 3, Queens OB/Gyn Objectives 1. Review the status of legalization of cannabis products in Canada and the potential impact on the obstetric population. 2. Assess the literature to date on the safety of in-utero exposure to cannabis to the fetus and mother. 3. Discuss management considerations and propose treatment options throughout the antenatal and postpartum period in mothers who use cannabis products. 4. Present a review of the cannabinoid hyperemesis syndrome vs cyclic vomiting syndrome. 5. Compare the current guidelines on marijuana use while breastfeeding 6. Review limitations of urine drug screening for assessment of marijuana use Disclosures In the News I have nothing to disclose But surely not... A Lack of High Quality Research - Cannabis is the most commonly used illicit drug in pregnancy - Self reports of use are 2.3% - Prospective cohort studies: % in middle-class % in inner-city - Highest use during first trimester ( 10.7%) The Reproductive Health Working Group 2006 Day, Leech & Goldschmidt, 2011; Fried,

2 a. Say okay and move on because you do not have solid evidence it s bad? b. b. Tell her to stop smoking marijuana immediately because it is harmful to her growing baby? c. c. Discuss harm reduction options? What do our guidelines say? ACOG COMMITTEE OPINION - Screen all women for tobacco, alcohol and other drug abuse - Women reporting marijuana use should be counseled about concerns regarding potential adverse health consequences of continued use during pregnancy. - Women who are pregnant or contemplating pregnancy should be encouraged to discontinue marijuana use. - Pregnant women or women contemplating pregnancy should be encouraged to discontinue use of marijuana for medicinal purposes in favor of an alternative therapy for which there are better pregnancy-specific safety data. - There are insufficient data to evaluate the effects of marijuana use on infants during lactation and breastfeeding, and in the absence of such data, marijuana use is discouraged. SOGC GUIDELINE ON SUBSTANCE ABUSE - All pregnant women should be asked periodically about alcohol, tobacco, prescription and illicit drug use (III-A) - Women should be counselled about the risks of periconception, antepartum, and postpartum substance use. (III-B) - Health care providers should advise pregnant women to abstain from or reduce cannabis use during pregnancy to prevent negative long-term cognitive and behavior outcomes for exposed children (II-1A) - Health care providers should employ a flexible and harm reduction approach to the care of pregnant women who use alcohol, tobacco or drugs. They should be offered brief interventions and referral to community resources for further psychosocial interventions - When testing for substance use is clinically indicated, urine drug screening is the preferred method. (II-2A) Informed consent should be obtained from the woman before maternal drug toxicology testing is ordered. (III-B) - Policies and legal requirements with respect to drug testing of newborns may vary by jurisdiction, and caregivers should be familiar with the regulations in their region. (III-A) What good quality studies can we turn to? OPPs ( Ottawa Prenatal Prospective Study) - Started in Mostly caucasian middle-class families MHPCD ( Maternal Health Practices and Child Development) - Pittsburgh in Mostly african-american women from low SES background Generation R - Started in Multi-ethnic with higher SES from the Netherlands. Maternal Outcomes - No association with gestational diabetes, anemia, gestational hypertension,postpartum hemorrhage or maternal weight gain has been reliably reproduced. CCSA: Clearing the smoke on Cannabis,

3 Neonatal Outcomes - Preterm Birth - Low Birth weight Yes in Gen R, No in OPPs?Potency effect. Meta-analysis have not shown a strong association. - 5 fold increase in FASD features - Neurological Sequelae ( OPPS, MHPCD, Gen R) - decreased self-quieting ability - increased fine tremors and startles - increased hand-to-mouth activity - sleep pattern changes CCSA: Clearing the smoke on Cannabis, 2015 CCSA: Clearing the smoke on Cannabis, 2015 Recommended Resources - Is she addicted? - Could she go into withdrawal? - If she can t quit cold turkey are there ways to make it safer while she cuts down slowly? ( harm reduction) Cannabis Use Disorder - DSM 5 Same criteria as for other substance use disorders: Involves a pathological set of behaviors related to the use of a cannabis that fall into 4 main categories: 1. Impaired control ( using more than intended, not able to stop etc) 2. Social impairment ( use despite interference with work, relationships etc) 3. Risky use ( use while driving etc) 4. Tolerance and withdrawal Need to meet 2 of these criteria for diagnosis Cannabis withdrawal (DSM 5) - Criteria A: Cessation of cannabis use that has been heavy and prolonged - Criteria B: > 3 of the following 7 symptoms: - Anger, irritability or feelings of aggression - Depressed mood - Feelings of restlessness - A loss of appetite (or weight loss) - Insomnia or other sleeping problems - Feelings of anxiety or nervousness - Physical symptoms of withdrawal, such as headache, stomach pains, increased sweating, fever, chills or shakiness (enough to cause significant discomfort) - Criteria C: The symptoms in Criterion B cause clinically significant distress or impairment in social, occupational, or other important areas of functioning - Criteria D. The symptoms are not due to a general medical condition and are not better accounted for by another disorder 3

4 Not Just Cannabis Quitting Cannabis 8% of people who try marijuana will develop cannabis dependence Outpatient treatment programs provide modest benefit - Any treatment program is better than none - no modality or duration of treatment has been proven superior No pharmacotherapy has been shown to be effective in mitigating withdrawal symptoms other than THC replacement therapies. Nordstrom and Levin, 2007 Tapering Nabilone - Start at 0.5mg qhs and ask the patient to try to taper down her consumption of cannabis products. - Titrate up to 0.5mg BID to target nausea and increase appetite - Increase by 0.5mg at a time with titration qweekly until able to abstain completely from cannabis products. Harm Reduction options - Use vaporizer - Avoid deep inhalation and breath holding - Avoid smoking with tobacco and higher potency cannabis - Wait 4 hours after smoking before driving - Only the 0.5mg nabilone capsule is covered by ODB - Can marijuana really make me retch and vomit so much? - I thought marijuana made nausea and vomiting better. Cannabinoid Hyperemesis Syndrome 3 Features: - Chronic Cannabis use - Cyclic episodes of Nausea and Vomiting - Frequent hot bathing Often confused with Cyclic Vomiting Syndrome Galli JA, Sawaya RA, Friedenberg FK.,

5 Cyclic Vomiting Syndrome - Episodes of nausea/vomiting and diffuse abdominal pain with acute onset lasting <1 week - Absence of nausea and vomiting between episodes - > 3 episodes per year, may be triggered by psychological stressors. - Cannabis may be used to self medicate, no improvement in episode frequency if stopped - Family or personal history of migraines - Hot showers not helpful - Acute treatment :anti-migraine meds, supportive care, psych support. - Prophylaxis: avoid triggers, TCA Cannabinoid Hyperemesis Syndrome - Episodes of nausea/vomiting and diffuse abdominal pain with acute onset lasting typically hrs - Absence of nausea and vomiting between episodes - History of chronic cannabinoid use - Recurrence likely if continue to use cannabinoids. - Hot showers helpful - Acute treatment: supportive, abstain from cannabinoids. - Prophylaxis: no cannabis Galli JA, Sawaya RA, Friedenberg FK., Now that I ve delivered can I have a joint every once in awhile? - Will you call family and children s services if I do? Marijuana and Breastfeeding - THC is fat soluble and is excreted in human breast milk in moderate amounts - In heavy users milk:plasma ratio can be as high as 8:1 Breastfeeding Recommendations - Motherisk, AAP, ABM, ACOG recommend avoidance of cannabis products while breastfeeding - Decreased motor development at 1 year - Probable increased risk of SIDS -?Compromise ability to care for child - No long term data beyond 1 year - Only the ABM has made a position statement regarding abstinence from breastfeeding in the setting of continued use. MOTHERISK, Academy of Breastfeeding Medicine Child Protection - Marijuana use is a gray zone - Independently not necessarily an indication to contact family and children s services, but may contribute to the whole picture - Both woman and child should receive additional supports - Discuss ability to parent while impaired: who is the designated parent? Urine Drug Testing - Urine drug testing for marijuana can stay positive for up to 30 days - Urine testing can be positive from second-hand exposure but only with exposure in unventilated areas, and likely only positive shortly after exposure Cone and Bigelow,

6 I m still smoking marijuana every night before bed, it s safe cause it s natural right? - Counsel regarding the risks of marijuana use in pregnancy including lower birth weight, possible increase in FASD features, long term neurodevelopmental concerns - Advise to abstain in pregnancy - If not able to abstain advise re: harm reduction Am I addicted? Will I go into withdrawal? - It is possible to be addicted to marijuana and the features of addiction are the same as for other addictions including tolerance and withdrawal, - Withdrawal is characterised by shakes, anxiety, depression, N/V, diarrhea, insomnia. - A potential strategy to mitigate these symptoms is a tapering dose of nabilone while weaning off of cannabis products. Can marijuana really make me retch and vomit so much? - Yes, chronic use can cause cannabis hyperemesis syndrome characterised by cyclical vomiting and abdominal pain and frequent hot bathing. - The only cure is to stop using cannabis products and recurrence is common with resumption of use. Now that I ve delivered can I have a joint every once in awhile? - Marijuana is secreted in breastmilk at up to 8x maternal serum levels - Recommendation is to abstain from marijuana while breastfeeding though evidence is limited regarding the risks. Will you call family and children s services if I do? - Cannabis use itself is not an indication to contact Children s Aid when used responsibly. Thank you Any Questions? - Discuss the importance of the sober parent, avoiding secondhand smoke exposure and offer supports. - Urine drug screens can stay positive for up to 30 days and it is possible to have a positive UDS after significant second hand exposure. 6

Marijuana in Pregnancy

Marijuana in Pregnancy Idaho Perinatal Project 2019 Winter Conference Marijuana in Pregnancy What are we telling our patients? Stacy T. Seyb, MD Kristy Schmidt, MN, RN, NEA-BC Special Thanks to Tori Metz, MD University of Utah

More information

MARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN

MARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN MARIJUANA USE AMONG PREGNANT AND POSTPARTUM WOMEN Symposium on Marijuana Research in Washington May 18, 2018 THERESE GRANT, PH.D. PROFESSOR, DEPARTMENT OF PSYCHIATRY & BEHAVIORAL SCIENCES UNIVERSITY OF

More information

Counseling Guidelines: Breastfeeding and Maternal Alcohol, Tobacco and Other Drug Use

Counseling Guidelines: Breastfeeding and Maternal Alcohol, Tobacco and Other Drug Use Counseling Guidelines: Breastfeeding and Maternal Alcohol, Tobacco and Other Drug Use May 2008 These guidelines were developed by the Sonoma County Breastfeeding Coalition and the Sonoma County Perinatal

More information

What To Expect. Maternal Cannabis Use during Pregnancy and the Impacts on Offspring

What To Expect. Maternal Cannabis Use during Pregnancy and the Impacts on Offspring www.ccsa.ca www.cclt.ca What To Expect Maternal Cannabis Use during Pregnancy and the Impacts on Offspring Presentation for: 2016 Best Start Conference Amy Porath-Waller, PhD Katie Fleming, MA February

More information

Important Information

Important Information Important Information Please work through the following pages with your patient or the patient s chart as necessary. Fax completed documents to 1 888 629-4722. Keep the original in your chart / file. Fee:

More information

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS

CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS CANNABIS LEGALIZATION: SUPPORT MATERIAL FOR MANITOBA PHYSICIANS 1. GENERAL INFORMATION Cannabis 101 What is cannabis? Cannabis is a product derived from the Cannabis sativa plant. Cannabis contains hundreds

More information

Effects of Prenatal Illicit Drug. Use on Infant and Child

Effects of Prenatal Illicit Drug. Use on Infant and Child Effects of Prenatal Illicit Drug Use on Infant and Child Development Andrew Hsi, MD, MPH Larry Leeman, MD, MPH Family Medicine MCH Grand Rounds 6 July 2011 Objectives for Presentation At the end of this

More information

Marijuana in Pregnancy. Kimberly Butt MD, FRCSC, MFM Fredericton, NB ASOG September 15,2017

Marijuana in Pregnancy. Kimberly Butt MD, FRCSC, MFM Fredericton, NB ASOG September 15,2017 Marijuana in Pregnancy Kimberly Butt MD, FRCSC, MFM Fredericton, NB ASOG September 15,2017 Outline Background Biologic effects Legislation Concerns for pregnancy Concerns for breast feeding Summary Disclosure

More information

Consumer Information Cannabis (Marihuana, marijuana)

Consumer Information Cannabis (Marihuana, marijuana) Consumer Information Cannabis (Marihuana, marijuana) The courts in Canada have ruled that the federal government must provide reasonable access to a legal source of marijuana for medical purposes. The

More information

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION

4/15/2019. US States with Marijuana Laws in Have ACOG and SMFM taken notice? THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION THE EFFECTS OF MARIJUANA USE ON PREGNANCY AND LACTATION Susan R Davidson, MD Maternal Fetal Medicine Department of Ob/Gyn St. Mary s Hospital Madison, WI SSM Health I HAVE NO FINANCIAL DISCLOSURES TO REPORT

More information

Understanding Prenatal Drug Exposure

Understanding Prenatal Drug Exposure Understanding Prenatal Drug Exposure Prenatal Drug Exposure A mother s drug use hurts her unborn baby. Slide 2 Drug Categories Part 1 Prescription drugs: Prescribed by a doctor and used under a health

More information

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making

Acknowledgements: What it is What it s not. Cannabis Evidence Series. Evidence-informed decision-making Cannabis Evidence Series What it is What it s not Acknowledgements: The evidence presented is from the Cannabis evidence series authored by the HTA unit at the University of Calgary and from Rapid response

More information

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012)

Neonatal Abstinence Syndrome Questions & Answers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) Neonatal bstinence Syndrome Questions & nswers Webinar #1 (February 9, 2012) Webinar #2 (March 30, 3012) For more information and to download a copy of the NS Clinical Practice Guidelines, please visit

More information

A look at Marijuana in 2014

A look at Marijuana in 2014 A look at Marijuana in 2014 Paul Snyder MA., LADC Overview and Objectives Discuss the mental and physical effects of marijuana use Describe the criteria for Cannabis use disorder according to the DSM 5

More information

Marijuana Use During Pregnancy and Breastfeeding Findings Summary

Marijuana Use During Pregnancy and Breastfeeding Findings Summary The Colorado Department of Public Health and Environment (CDPHE) was assigned the responsibility to appoint a panel of health care professionals with expertise in cannabinoid physiology to monitor the

More information

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD

Product Labeling to Communicate Benefits and Risks of Treatment for Opioid Use Disorder in Pregnant Women. Hendrée E. Jones, PhD 1 The National Academies of Sciences, Engineering and Medicine Regulatory Strategies of address prescription opioidrelated harms 4 th of November, 2016 Washington DC Product Labeling to Communicate Benefits

More information

SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS

SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS SUBSTANCE EXPOSED INFANTS PRESENTED BY ECOLE J. BARROW-BROOKS M.ED & DARLENE D. OWENS MBA, LBSW, CADC, ADS 1 SUBSTANCE-EXPOSED INFANTS Refers to infants exposed to alcohol and or other substances ingested

More information

Substance Use in Pregnancy and Breastfeeding Lisa Graves MD CCFP FCFP

Substance Use in Pregnancy and Breastfeeding Lisa Graves MD CCFP FCFP + Substance Use in Pregnancy and Breastfeeding Lisa Graves MD CCFP FCFP Physician CATC clinics Sudbury and Parry Sound ON Professor Family and Community Medicine Western Michigan University Homer Stryker

More information

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain Due to the high level of prescription drug use and abuse in Lake County, these guidelines have been developed to standardize prescribing habits and limit risk of unintended harm when prescribing opioid

More information

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access

Objectives. 1. Review controversy 2. Pathophysiology 3. Indications for Use 4. Adverse Effects 5. How Patients Access Medical Marijuana Deb Evans, RN, MScN, CON(C), CHPCN(C) Clinical Nurse Specialist Pain and Symptom Management Team Juravinski Cancer Centre May 29, 2014 Objectives 1. Review controversy 2. Pathophysiology

More information

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome

Opioid Use Disorder in Pregnancy. Neonatal Abstinence Syndrome Opioid Use Disorder in Pregnancy Neonatal Abstinence Syndrome Opioid Use Disorder and Pregnancy Cont. 4.6 million women (or 3.8 percent) ages 18 and older misused prescription drugs in 2013. One-third

More information

INITIAL PATIENT INTAKE FORM

INITIAL PATIENT INTAKE FORM INITIAL PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional use only.

More information

10 Questions to Ask. Before You Use Marijuana

10 Questions to Ask. Before You Use Marijuana 10 Questions to Ask Before You Use Marijuana 1 You ve probably heard conflicting opinions about marijuana and its risks. The health information included here is based on recent studies done by researchers

More information

Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions

Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions Jill M Williams, MD Professor Psychiatry Director, Division Addiction Psychiatry Robert Wood Johnson Medical School Disclosures

More information

4/15/2019. Dickson, et al Obstet Gynecol Marijuana Use and Pregnancy. Conner, et al AJOG Conner, et al Obstet and Gynecol 2016

4/15/2019. Dickson, et al Obstet Gynecol Marijuana Use and Pregnancy. Conner, et al AJOG Conner, et al Obstet and Gynecol 2016 Dickson, et al Obstet Gynecol 2018 69% of dispensaries (277/400) recommended cannabis products for morning sickness Of those who recommended cannabis for morning sickness 65% based their recommendation

More information

Dr. Meldon Kahan. Women s College Hospital. with PIA LAW

Dr. Meldon Kahan. Women s College Hospital. with PIA LAW with PIA LAW and Toronto ABI Network Dr. Meldon Kahan Women s College Hospital Dr. Meldon Kahan is an Associate Professor in the Department of Family Medicine at University of Toronto, and Medical Director

More information

Management of Perinatal Tobacco Use

Management of Perinatal Tobacco Use Management of Perinatal Tobacco Use David Stamilio, MD, MSCE Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, UNC School of Medicine Funding for this project is provided in

More information

Lessons Learned. Marijuana Education & Prevention in Colorado

Lessons Learned. Marijuana Education & Prevention in Colorado Lessons Learned Marijuana Education & Prevention in Colorado Jessica Neuwirth Retail Marijuana Education & Youth Prevention Coordinator, Prevention Services Division CDPHE ON Enact the will of the people

More information

Maternal Mental Health: Risk Factors, Ramifications, and Roles. Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy

Maternal Mental Health: Risk Factors, Ramifications, and Roles. Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy Maternal Mental Health: Risk Factors, Ramifications, and Roles Anna Glezer MD UCSF Assistant Clinical Professor Founder, Mind Body Pregnancy Disclosures None Objectives for Today Review major maternal

More information

Cannabis in the Community

Cannabis in the Community Department of Pediatrics Cannabis in the Community The Unintended Consequences of Increased Marijuana Availability on the Pediatric Population Karen Buchi, MD Professor of Pediatrics Chair, University

More information

CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE

CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE 1 CANNABIS AND CANNABINOIDS: 2017 REPORT, U.S. NATIONAL ACADEMIES OF SCIENCES, ENGINEERING AND MEDICINE The Health Effects of Cannabis and Cannabinoids. The Current State of Evidence and Recommendations

More information

Blazing the Trail in Colorado Marijuana and Public Health

Blazing the Trail in Colorado Marijuana and Public Health Blazing the Trail in Colorado Marijuana and Public Health Tista Ghosh, MD, MPH November 2012 1 Public Health Responsibilities 1. Monitor patterns of use 2. Monitor health outcomes 3. Create a scientific

More information

EVALUATING PERINATAL MOOD DISORDERS. For Healthcare Providers

EVALUATING PERINATAL MOOD DISORDERS. For Healthcare Providers EVALUATING PERINATAL MOOD DISORDERS For Healthcare Providers Nothing to disclose Educational Objectives Understand Perinatal Mood Disorders Describe appropriate screening procedures for perinatal mood

More information

Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff.

Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff. Prenatal and Post Partum Depression is Not Just a Mood. This is Serious Stuff. Deborah McMahan, MD Health Commissioner Prenatal and Infant Care Network November 28, 2016 Agenda Prevalence of mental illness

More information

Women s Mental Health

Women s Mental Health Women s Mental Health Linda S. Mullen, MD Director, Women s Mental Health Assistant Professor of Clinical Psychiatry in OB/GYN Columbia University & NewYork Presbyterian Hospital Departments of Psychiatry

More information

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome

NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome NOWS The Time Caring for the Infant with Neonatal Opiate Withdrawal Syndrome Meghan Howell, MD FAAP Assistant Professor of Pediatrics Clinical Director, Tulane NICU Graduate Clinic Tulane University School

More information

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets Read this Medication Guide carefully before you start using WELLBUTRIN and each time you get a refill. There may be new information.

More information

Special Populations: Guidelines for Pregnant Smokers

Special Populations: Guidelines for Pregnant Smokers Special Populations: Guidelines for Pregnant Smokers Jennifer S. B. Moran, MA Mayo Clinic Best Practice Brief cessation counseling 5-15 minutes by a trained health care provider, combined with pregnancyspecific

More information

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Smoking Cessation in Pregnancy Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Tobacco Cessation in Pregnancy: Objective 1. Overview of the negative effects of tobacco abuse in

More information

MARIJUANA IN PREGNANCY: Now that it is legal

MARIJUANA IN PREGNANCY: Now that it is legal MARIJUANA IN PREGNANCY: Now that it is legal June 7, 2018 42 nd Annual Antepartum and Intrapartum Management No financial disclosures DISCLOSURES Lena H. Kim, MD MFM, Sutter Health, California Pacific

More information

When you drink, your baby drinks too. Drinking alcohol during

When you drink, your baby drinks too. Drinking alcohol during Alcohol and Pregnancy Don t Mix When you drink, your baby drinks too. Drinking alcohol during pregnancy could cause your baby to be born with Fetal Alcohol Spectrum Disorder (FASD) or other alcohol-related

More information

Fatty Acid Oxidation Disorders

Fatty Acid Oxidation Disorders Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social

More information

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Referral to the Women s Alcohol and Drug Service (WADS) Procedure Procedure Referral to the Women s Alcohol and Drug Service (WADS) Procedure. Purpose The following document describes criteria for the referral to Women s Alcohol and Drug Service (WADS) and how a referral

More information

Marijuana: The Facts

Marijuana: The Facts Marijuana: The Facts Everybody s Doing It FALSE! 78% of Ball State students have NOT used marijuana in the last month. Only 5.9% of BSU students are daily users. Source: National College Health Assessment

More information

Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital

Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital Is there a role for medical marijuana in the management of IBD? Jami A. Kinnucan, MD Division of Gastroenterology University of Michigan Hospital Disclosures No relevant financial or relationship disclosures

More information

Referral to the Women s Alcohol and Drug Service (WADS) Procedure

Referral to the Women s Alcohol and Drug Service (WADS) Procedure 1. Purpose The following document describes criteria for the referral to Women s Alcohol and Drug Service (WADS) and how a referral is taken and processed. This includes the referral for clinical care

More information

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015

Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Maternal Substance Abuse: Challenges & Opportunities for Perinatal Nurses Catherine H. Ivory, PhD, RNC-OB October, 2015 Objectives Discuss the current scope of maternal substance use and abuse List examples

More information

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY

8/24/2015 ADDICTION AND PREGNANCY. Fear ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION & PREGNANCY ADDICTION AND PREGNANCY L y n é e B r o w n, M A, C D P & D o n n a L i v i n g s t o n, R N A D A P T E D F R O M J i m W a l s h, M D Objectives: Recognize common fears and myths associated with substance

More information

Blazing the Trail in Colorado Marijuana and Public Health. Tista Ghosh, MD, MPH

Blazing the Trail in Colorado Marijuana and Public Health. Tista Ghosh, MD, MPH Blazing the Trail in Colorado Marijuana and Public Health Tista Ghosh, MD, MPH History of Medical Marijuana in Colorado Amendment 20 - November 2000 July 2001 Registry established Ogden Memorandum 2009

More information

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome

The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome Neonatal Nursing Education Brief: The Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome https://www.seattlechildrens.org/healthcareprofessionals/education/continuing-medical-nursing-education/neonatalnursing-education-briefs/

More information

Funding for TIPS provided by: The State of Tennessee Portions of this presentation 2002 The American College of Obstetricians and Gynecologists

Funding for TIPS provided by: The State of Tennessee Portions of this presentation 2002 The American College of Obstetricians and Gynecologists A training offered by Dr. Beth Bailey, Associate Professor of Family Medicine, East Tennessee State University; and by the Tennessee Intervention for Pregnant Smokers (TIPS) Program Funding for TIPS provided

More information

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Buprenorphine Initiation and Maintenance in Pregnancy (Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Assessment The diagnosis of OUD should be confirmed by DSM-5

More information

Tuscarawas County Health Department. Vivitrol Treatment Consent

Tuscarawas County Health Department. Vivitrol Treatment Consent Tuscarawas County Health Department Vivitrol Treatment Consent I. Vivitrol Medication Guide: a. VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) b. Read this Medication Guide

More information

Fatty Acid Oxidation Disorders

Fatty Acid Oxidation Disorders Genetic Fact Sheets for Parents Fatty Acid Oxidation Disorders Screening, Technology, and Research in Genetics is a multi-state project to improve information about the financial, ethical, legal, and social

More information

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center

Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center Lori A. Shook, MD Division of Neonatology Kentucky Children s Hospital University of Kentucky Medical Center NSDUH, 2012 National Survey on Drug Use and Health: 2012 Substance abuse: Public Health Problem

More information

Medical Cannabis: A Patient Primer

Medical Cannabis: A Patient Primer Medical Cannabis: A Patient Primer This primer is meant for documented patients who are using medicinal cannabis or considering using it in the future. The information provided about this medication in

More information

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Legalized Marijuana: Uses, Misuses & Abuses Kennon Heard University of Colorado SOM Dept Of Emergency Medicine Disclosures Research grants McNeil Consumer Healthcare (Acetaminophen) Rare Disease Therapeutics

More information

Cannabis Hyperemesis Syndrome: An Emerging Cause of Intractable Nausea & Vomiting

Cannabis Hyperemesis Syndrome: An Emerging Cause of Intractable Nausea & Vomiting Cannabis Hyperemesis Syndrome: An Emerging Cause of Intractable Nausea & Vomiting Morganna Freeman-Keller, DO ACP Associate Member University of Florida Internal Medicine Residency Program Public Health

More information

Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment

Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment Continuing Education Webinar The Pregnancy Opioid Epidemic: An Outpatient Medical Home Approach to Treatment This webinar will be recorded and available on the NPIC/QAS website www.npic.org. Nurse Planner:

More information

5/24/ Maria H. Elswick, MD. Maternal Wellness Program Physician Lead

5/24/ Maria H. Elswick, MD. Maternal Wellness Program Physician Lead Maria H. Elswick, MD Maternal Wellness Program - Physician Lead Department of Obstetrics & Gynecology Kaiser Permanente San Diego Maria H. Elswick, MD Maternal Wellness Program Physician Lead Department

More information

Licit or Illicit Use: Nicotine, Alcohol, Caffeine, and Cannabis. Joelle Puccio BSN RN

Licit or Illicit Use: Nicotine, Alcohol, Caffeine, and Cannabis. Joelle Puccio BSN RN Licit or Illicit Use: Nicotine, Alcohol, Caffeine, and Cannabis Joelle Puccio BSN RN Nicotine in Pregnancy Nicotine is a naturally occurring chemical present in large quantities in tobacco, and small quantities

More information

Is cannabis addictive? CANNABIS EVIDENCE BRIEF

Is cannabis addictive? CANNABIS EVIDENCE BRIEF Is cannabis addictive? CANNABIS EVIDENCE BRIEF BRIEFS AVAILABLE IN THIS SERIES: Is cannabis safe to use? Facts for youth aged 13 17 years. Is cannabis safe to use? Facts for young adults aged 18 25 years.

More information

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home

More information

MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution

MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution IMPORTANT: Keep morphine sulfate oral solution in a safe place away from children. Accidental use by a child is a medical emergency

More information

Tobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH

Tobacco Cessation for Women of Reproductive Age. Erin McClain, MA, MPH Tobacco Cessation for Women of Reproductive Age Erin McClain, MA, MPH Tobacco Use During Pregnancy in NC 2 1 in 10 babies in NC are born to women reporting tobacco use during pregnancy In some counties

More information

Torri Metz, MD Maternal-Fetal Medicine December 15, 2017

Torri Metz, MD Maternal-Fetal Medicine December 15, 2017 Torri Metz, MD Maternal-Fetal Medicine December 15, 2017 I have no relevant financial relationships to disclose or conflicts of interest to resolve. Describe public health impact of expanding marijuana

More information

MOSBIRT - Personal Health Risk Assessment

MOSBIRT - Personal Health Risk Assessment Participant: Test, Amy (9987631) Assessed: Wednesday, February 01, 2012 About this report: Like most women you face a lot of responsibilities and decisions every day. These include how you take care of

More information

1/26/2018 PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES THE PROBLEM RISK FACTORS FOR ENDANGERMENT

1/26/2018 PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES THE PROBLEM RISK FACTORS FOR ENDANGERMENT PREVENTING THE RETRAUMITIZATION OF CHILDREN FROM ADDICTED FAMILIES Susan Kilman LCSW, AADC THE PROBLEM ABOUT 1 IN 8 (8.7 MILLION) AGED 17 OR YOUNGER LIVE IN HOUSEHOLDS WITH AT LEAST ONE PARENT WHO HAD

More information

Marijuana During Pregnancy: An Overview

Marijuana During Pregnancy: An Overview Marijuana During Pregnancy: An Overview Marijuana: Epidemiology Marijuana is the most commonly used illicit drug and, after alcohol and tobacco, the most commonly used drug during pregnancy (1) 48-60%

More information

A GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX

A GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX A GUIDE TO TALKING WITH YOUR DOCTOR ABOUT EPIDIOLEX You are encouraged to have an open conversation with your doctor about your treatment goals and current medicines. It is important in determining if

More information

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

*IN10 BIOPSYCHOSOCIAL ASSESSMENT* BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding

More information

Perinatal Substance Use: Evidence for Current Practice. Karen Clemmer, MCAH Coordinator, Sonoma County

Perinatal Substance Use: Evidence for Current Practice. Karen Clemmer, MCAH Coordinator, Sonoma County Perinatal Substance Use: Evidence for Current Practice Karen Clemmer, MCAH Coordinator, Sonoma County The impact of perinatal marijuana use on pregnancy outcomes & lactation Learning Objectives Influence

More information

CAPC/CPNP Coalition Face to Face Meeting October 18, 2018

CAPC/CPNP Coalition Face to Face Meeting October 18, 2018 CAPC/CPNP Coalition Face to Face Meeting October 18, 2018 Topics What is cannabis and how is it used? What does the evidence say about health effects? What about effects during pregnancy and breastfeeding?

More information

Buprenorphine Patch (Transtec Patch)

Buprenorphine Patch (Transtec Patch) NHS Greater Glasgow And Clyde Pain Management Service Information for Adult Patients who are Prescribed Buprenorphine Patch (Transtec Patch) For the Treatment of Pain Contents Page What is a transtec patch?...

More information

FASD Prevention and Health Promotion Resources

FASD Prevention and Health Promotion Resources FASD PREVENTION AND HEALTH PROMOTION RESOURCES FASD Prevention and Health Promotion Resources Module 2 Brief Intervention and Motivational Interviewing September 2017 Review Module 1: What is FASD? Module

More information

Addiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018

Addiction and Pregnancy. Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018 Jim Walsh, MD Medical Director Addiction Recovery Service Swedish Medical Center WSADCP October 2018 Fear Shame Commitment Barriers Opportunities Fear Thalidomide induced phocomelia 1957 Fear Fetal Alcohol

More information

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION What is the most important information I should know about SUBOXONE Film? Keep SUBOXONE Film in a secure place

More information

Doctor Discussion Guide

Doctor Discussion Guide Doctor Discussion Guide Getting the pain relief you need to stay active is important. Keeping track of your symptoms can help you and your healthcare provider determine if there is a need to adjust your

More information

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets

MEDICATION GUIDE WELLBUTRIN (WELL byu-trin) (bupropion hydrochloride) Tablets Page 25 the 75- or 100-mg tablets. The 100-mg tablet must be administered 4 times daily with at least 4 hours between successive doses, in order not to exceed the limit of 150 mg in a single dose. WELLBUTRIN

More information

MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules

MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules Read this Medication Guide before you start taking Valproic Acid Capsules and each time you get a refill. There may be new information. This information

More information

Supersedes Date None and Management Guidelines. Originating Dept. NICU Document Owner Dir., NICU Document applies to: NCH Required Not Required

Supersedes Date None and Management Guidelines. Originating Dept. NICU Document Owner Dir., NICU Document applies to: NCH Required Not Required Effective Date 12/13/16 Neonatal Abstinence Syndrome (NAS) Date Approved 12/13/16 Guideline Pharmacologic Protocol Supersedes Date None and Management Guidelines Originating Dept. NICU Document Owner Dir.,

More information

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including:

Venlafaxine hydrochloride extended-release and other antidepressant medicines may cause serious side effects, including: Medication Guide VENLAFAXINE XR (venlafaxine hydrochloride) (Extended-Release Capsules) Read the Medication Guide that comes with venlafaxine hydrochloride extended-release before you start taking it and

More information

ISSUE: BACKGROUND: CanFASD Issue Paper: Cannabis Use During Pregnancy. March 2018

ISSUE: BACKGROUND: CanFASD Issue Paper: Cannabis Use During Pregnancy. March 2018 CanFASD Issue Paper: Cannabis Use During Pregnancy Kelly D. Harding, PhD and Nancy Poole, PhD Canada Fetal Alcohol Spectrum Disorder Research Network ISSUE: In 2018, the Canadian government plans to introduce

More information

Annex I. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s)

Annex I. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) Annex I Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) 1 Scientific conclusions Taking into account the PRAC Assessment Report on the PSUR(s) for topiramate,

More information

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin

More information

Tobacco Cessation For Providers. Betty Murphy Health Promotion Program Naval Hospital Rota

Tobacco Cessation For Providers. Betty Murphy Health Promotion Program Naval Hospital Rota Tobacco Cessation For Providers Betty Murphy Health Promotion Program Naval Hospital Rota Tobacco Statistics Strategies for Implementation Stages of Change Pharmacotherapy Tobacco Use Statistics 70% of

More information

MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP

MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP IMPORTANT: Keep oxycodone hydrochloride oral solution in a safe place away from children. Accidental use by a child is

More information

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell: PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: / / Gender: Male Female Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell: Email: Primary

More information

These documents were created to support the work of the Coalition of Colorado Campus Alcohol and Drug Educators. We welcome prevention teams at

These documents were created to support the work of the Coalition of Colorado Campus Alcohol and Drug Educators. We welcome prevention teams at These documents were created to support the work of the Coalition of Colorado Campus Alcohol and Drug Educators. We welcome prevention teams at institutions of higher education to utilize these documents

More information

Adult Health History Form Preferred Name: 1

Adult Health History Form Preferred Name: 1 Adult Health History Form Preferred Name: 1 Your answers on this form will help your health care provider get an accurate history of your medical concerns and conditions. If you are uncomfortable with

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION ORILISSA. elagolix (as elagolix sodium) tablets

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION ORILISSA. elagolix (as elagolix sodium) tablets READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION ORILISSA elagolix (as elagolix sodium) tablets Read this carefully before you start taking ORILISSA and each time you

More information

Talking with your doctor

Talking with your doctor SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may

More information

MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only

MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency

More information

Drugs cross the placenta producing a new set of pharmacokinetics.

Drugs cross the placenta producing a new set of pharmacokinetics. SUBSTANCE ABUSE IN PREGNANCY Aidan Foy Director, Alcohol and Drug Services, Newcastle Mater Misericordiae Hospital Introduction Substances used in pregnancy can interfere with the success of the pregnancy

More information

Consequences and Treatment of Opioid Abuse During Pregnancy. Katie Ellis, PharmD March 12, 2018

Consequences and Treatment of Opioid Abuse During Pregnancy. Katie Ellis, PharmD March 12, 2018 Consequences and Treatment of Opioid Abuse During Pregnancy Katie Ellis, PharmD March 12, 2018 Disclosure I have nothing to disclose. Objectives At the completion of this activity, the pharmacist will

More information

Common Diagnosis Codes and Tips for Coding Nicotine Use/

Common Diagnosis Codes and Tips for Coding Nicotine Use/ ICD-10 Tobacco Billing Guide ICD-10 and Tobacco Common Diagnosis Codes and Tips for Coding Nicotine Use/ Dependence Tobacco use is the leading cause of preventable disease and death in the United States,

More information

MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution

MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution MEDICATION GUIDE Morphine Sulfate (mor-pheen) (CII) Oral Solution IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency and

More information

FACTS ABOUT PERTUSSIS (WHOOPING COUGH)

FACTS ABOUT PERTUSSIS (WHOOPING COUGH) FACTS ABOUT PERTUSSIS (WHOOPING COUGH) General Questions About Pertussis What is pertussis? Pertussis, or whooping cough, is a contagious illness that is spread when an infected person sneezes or coughs

More information

Tobacco Use and Reproductive Health: An Update

Tobacco Use and Reproductive Health: An Update Project with Alberta Health Services Christene Fetterly Gail Foreman and Tasha Allen Tobacco Use and Reproductive Health: An Update Lorraine Greaves PhD Nancy Poole PhD Natalie Hemsing, Research Associate,

More information